The important and diverse roles of antibodies in the host response to Borrelia infections

Current Topics in Microbiology and Immunology

Volumn 319, Issue , 2008, Pages 63-103

  LaRocca, T J ^a   Benach, J L ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IODINE 123; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; COMPLEMENT;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; AUTOIMMUNITY; B LYMPHOCYTE; BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI; BORRELIA HERMSII; BORRELIA INFECTION; BORRELIA RECURRENTIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMORAL IMMUNITY; IXODES SCAPULARIS; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREPONEMA; ANIMAL; BIOSYNTHESIS; BLOOD; BORRELIA; DISEASE CARRIER; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TICK;

BORRELIA; IXODIDA;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; BORRELIA; COMPLEMENT SYSTEM PROTEINS; HUMANS; INSECT VECTORS; LYME DISEASE; RELAPSING FEVER; T-LYMPHOCYTES; TICKS;

EID: 38449106997     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-73900-5_4     Document Type: Review

References (312)

1. Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC (1999) The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 67:173-181
2. Alaedini A, Latov N (2005) Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol 159:192-195
3. Alitalo A, Meri T, Lankinen H, Seppala I, Lahdenne P, Hefty PS, Akins D, Meri S (2002) Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J Immunol 169:3847-3853
4. Alitalo A, Meri T, Chen T, Lankinen H, Cheng ZZ, Jokiranta TS, Seppala IJ, Lahdenne P, Hefty PS, Akins DR, Meri S (2004) Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol 172:6195-6201
5. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170:3819-3827
6. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM (2004) B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21:379-390
7. Anda P, Sanchez-Yebra W, del Mar Vitutia M, Perez Pastrana E, Rodriguez I, Miller NS, Backenson PB, Benach JL (1996) A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet 348:162-165
8. Anderson JF, Magnarelli LA, McAninch JB (1988) New Borrelia burgdorferi antigenic variant isolated from Ixodes dammini from upstate New York. J Clin Microbiol 26:2209-2212
9. Anderson JF, Magnarelli LA, LeFebvre RB, Andreadis TG, McAninch JB, Perng GC, Johnson RC (1989) Antigenically variable Borrelia burgdorferi isolated from cottontail rabbits and Ixodes dentatus in rural and urban areas. J Clin Microbiol 27:13-20
10. Andersson M, Nordstrand A, Shamaei-Tousi A, Jansson A, Bergstrom S, Guo BP (2007) In situ immune response in brain and kidney during early relapsing fever borreliosis. J Neuroimmunol 183:26-32
11. Anderton JM, Tokarz R, Thill CD, Kuhlow CJ, Brooks CS, Akins DR, Katona LI, Benach JL (2004) Whole-genome DNA array analysis of the response of Borrelia burgdorferi to a bactericidal monoclonal antibody. Infect Immun 72:2035-2044
12. Anguita J, Rincon M, Samanta S, Barthold SW, Flavell RA, Fikrig E (1998) Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis 178:1512-1515
13. Axford JS, Rees DH, Mageed RA, Wordsworth P, Alavi A, Steere AC (1999) Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis. Ann Rheum Dis 58:757-761
14. Aydintug MK, Gu Y, Philipp MT (1994) Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect Immun 62:4929-4937
15. Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr (2003) Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci U S A 100:3031-3034
16. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ (2003) Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187:1187-1199
17. Bacon RM, Pilgard MA, Johnson BJ, Raffel SJ, Schwan TG (2004) Glycerophosphodiester phosphodiesterase gene (glpQ) of Borrelia lonestari identified as a target for differentiating Borrelia species associated with hard ticks (Acari:Ixodidae). J Clin Microbiol 42:2326-2328
18. Baig S, Olsson T, Link H (1989) Predominance of Borrelia burgdorferi specific B cells in cerebrospinal fluid in neuroborreliosis. Lancet 2:71-74
19. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PA (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378-383
20. Barbour AG (1990) Antigenic variation of a relapsing fever Borrelia species. Annu Rev Microbiol 44:155-171
21. Barbour AG (1991) Molecular biology of antigenic variation in Lyme borreliosis and relapsing fever: a comparative analysis. Scand J Infect Dis Suppl 77:88-93
22. Barbour AG, Bundoc V (2001) In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun 69:1009-1015
23. Barbour AG, Hayes SF (1986) Biology of Borrelia species. Microbiol Rev 50:381-400
24. Barbour AG, Tessier SL, Stoenner HG (1982) Variable major proteins of Borrellia hermsii. J Exp Med 156:1312-1324
25. Barbour AG, Tessier SL, Todd WJ (1983) Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 41:795-804
26. Barbour AG, Dai Q, Restrepo BI, Stoenner HG, Frank SA (2006) Pathogen escape from host immunity by a genome program for antigenic variation. Proc Natl Acad Sci U S A 103:18290-18295
27. Barstad PA, Coligan JE, Raum MG, Barbour AG (1985) Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides. J Exp Med 161:1302-1314
28. Barthold SW, Bockenstedt LK (1993) Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61:4696-4702
29. Barthold SW, deSouza M, Feng S (1996) Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 74:57-67
30. Barthold SW, Feng S, Bockenstedt LK, Fikrig E, Feen K (1997) Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 25 [Suppl 1]: S9-S17
31. Barthold SW, Hodzic E, Tunev S, Feng S (2006) Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun 74:4817-4825
32. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192:271-280
33. Beck G, Habicht GS, Benach JL, Coleman JL (1985) Chemical and biologic characterization of a lipopolysaccharide extracted from the Lyme disease spirochete (Borrelia burgdorferi). J Infect Dis 152:108-117
34. Becker M, Bunikis J, Lade BD, Dunn JJ, Barbour AG, Lawson CL (2005) Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. J Biol Chem 280:17363-17370
35. Belperron AA, Dailey CM, Bockenstedt LK (2005) Infection-induced marginal zone B cell production of Borrelia hermsii -specific antibody is impaired in the absence of CD1d. J Immunol 174:5681-5686
36. Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R (2003) A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A 100:7913-7918
37. Benach JL, Bosler EM, Hanrahan JP, Coleman JL, Habicht GS, Bast TF, Cameron DJ, Ziegler JL, Barbour AG, Burgdorfer W, Edelman R, Kaslow RA (1983) Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308:740-742
38. Benach JL, Fleit HB, Habicht GS, Coleman JL, Bosler EM, Lane BP (1984) Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J Infect Dis 150:497-507
39. Benach JL, Coleman JL, Golightly MG (1988) A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete. J Immunol 140:265-272
40. Bendelac A, Bonneville M, Kearney JF (2001) Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1:177-186
41. Bergstrom S, Bundoc VG, Barbour AG (1989) Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol 3:479-486
42. Beuche W, Siever A, Felgenhauer K (1992) Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosis. J Neurol 239:322-326
43. Bockenstedt LK, Barthold S, Deponte K, Marcantonio N, Kantor FS (1993) Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement. Infect Immun 61:2104-2107
44. Bockenstedt LK, Fikrig E, Barthold SW, Flavell RA, Kantor FS (1996) Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. J Immunol 157:5496-5502
45. Bockenstedt LK, Hodzic E, Feng S, Bourrel KW, de Silva A, Montgomery RR, Fikrig E, Radolf JD, Barthold SW (1997) Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun 65:4661-4667
46. Bolz DD, Sundsbak RS, Ma Y, Akira S, Weis JH, Schwan TG, Weis JJ (2006) Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp. Infect Immun 74:6750-6760
47. Brandt ME, Riley BS, Radolf JD, Norgard MV (1990) Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect Immun 58:983-991
48. Brooks CS, Vuppala SR, Jett AM, Alitalo A, Meri S, Akins DR (2005) Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J Immunol 175:3299-3308
49. Burgdorfer W, Gage KL (1986) Susceptibility of the black-legged tick, Ixodes scapularis, to the Lyme disease spirochete, Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg [A] 263:15-20
50. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317-1319
51. Burman N, Bergstrom S, Restrepo BI, Barbour AG (1990) The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol 4:1715-1726
52. Burroughs AL, Holdenried R (1944) Recovery of relapsing fever spirochetes from Ornithodoros turicata (Duges), 1876, in California. J Bacteriol 48:609
53. Cadavid D, Thomas DD, Crawley R, Barbour AG (1994) Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 179:631-642
54. Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG (2001) Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun 69:3389-3397
55. Cadavid D, Sondey M, Garcia E, Lawson CL (2006) Residual brain infection in relapsing-fever borreliosis. J Infect Dis 193:1451-1458
56. Calabi O (1959) The presence of plasma inhibitors during the crisis phenomenon in experimental relapsing fever (Borrelia novyi). J Exp Med 110:811-825
57. Callister SM, Schell RF, Lovrich SD (1991) Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol 29:1773-1776
58. Callister SM, Schell RF, Case KL, Lovrich SD, Day SP (1993) Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis 167:158-164
59. Callister SM, Schell RF, Lim LC, Jobe DA, Case KL, Bryant GL, Molling PE (1994) Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease. Arch Intern Med 154:1625-1632
60. Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD (1996) Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"? Clin Diagn Lab Immunol 3:399-402
61. Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D (1993) Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 25:441-448
62. Carter CJ, Bergstrom S, Norris SJ, Barbour AG (1994) A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun 62:2792-2799
63. Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC (1999) Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 42:1813-1822
64. Coffey EM, Eveland WC (1967a) Experimental relapsing fever initiated by Borella hermsi. I. Identification of major serotypes by immunofluorescence. J Infect Dis 117:23-28
65. Coffey EM, Eveland WC (1967b) Experimental relapsing fever initiated by Borrelia hermsi. II. Sequential appearance of major serotypes in the rat. J Infect Dis 117:29-34
66. Coleman JL, Rogers RC, Benach JL (1992) Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect Immun 60:3098-3104
67. Coleman JL, Rogers RC, Rosa PA, Benach JL (1994) Variations in the ospB gene of Borrelia burgdorferi result in differences in monoclonal antibody reactivity and in production of escape variants. Infect Immun 62:303-307
68. Connolly SE, Benach JL (2001) Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol 167:3029-3032
69. Connolly SE, Benach JL (2005) The versatile roles of antibodies in Borrelia infections. Nat Rev Microbiol 3:411-420
70. Connolly SE, Thanassi DG, Benach JL (2004) Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia. J Immunol 172:1191-1197
71. Cordes FS, Roversi P, Kraiczy P, Simon MM, Brade V, Jahraus O, Wallis R, Skerka C, Zipfel PF, Wallich R, Lea SM (2005) A novel fold for the factor H-binding protein BbCRASP-1 of Borrelia burgdorferi. Nat Struct Mol Biol 12:276-277
72. Cordes FS, Kraiczy P, Roversi P, Simon MM, Brade V, Jahraus O, Wallis R, Goodstadt L, Ponting CP, Skerka C, Zipfel PF, Wallich R, Lea SM (2006) Structure-function mapping of BbCRASP-1, the key complement factor H and FHL-1 binding protein of Borrelia burgdorferi. Int J Med Microbiol 296 [Suppl 40]:177-184
73. Creson JR, Lim LC, Glowacki NJ, Callister SM, Schell RF (1996) Detection of anti- Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and Western immunoblotting. Clin Diagn Lab Immunol 3:184-190
74. Croke CL, Munson EL, Lovrich SD, Christopherson JA, Remington MC, England DM, Callister SM, Schell RF (2000) Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 68:658-663
75. Crowley H, Alroy J, Sproule TJ, Roopenian D, Huber BT (2006) The MHC class I-related FcRn ameliorates murine Lyme arthritis. Int Immunol 18:409-414
76. Cutler SJ, Moss J, Fukunaga M, Wright DJ, Fekade D, Warrell D (1997) Borrelia recurrentis characterization and comparison with relapsing-fever, Lyme-associated, and other Borrelia spp. Int J Syst Bacteriol 47:958-968
77. Dai Q, Restrepo BI, Porcella SF, Raffel SJ, Schwan TG, Barbour AG (2006) Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol 60:1329-1343
78. Dame TM, Orenzoff BL, Palmer LE, Furie MB (2007) IFN-{gamma} alters the response of borrelia burgdorferi-activated endothelium to favor chronic inflammation. J Immunol 178:1172-1179
79. Damman CJ, Eggers CH, Samuels DS, Oliver DB (2000) Characterization of Borrelia burgdorferi BlyA and BlyB proteins: a prophage-encoded holin-like system. J Bacteriol 182:6791-6797
80. Davidson MM, Chisholm SM, Wiseman AD, Joss AW, Ho-Yen DO (1996) Improved serodiagnosis of Lyme disease. Clin Mol Pathol 49:M80-M84
81. Davis GE (1939) Relapsing fever: Ornithodoros hermsi a vector in Colorado. Public Health Report 54:2178-2180
82. Davis GE (1940) Ticks and relapsing fever in the United States. Public Health Report 55:2347-2351
83. de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E (1996) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183:271-275
84. de Silva AM, Zeidner NS, Zhang Y, Dolan MC, Piesman J, Fikrig E (1999) Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks. Infect Immun 67:30-35
85. Dressler F, Whalen JA, Reinhardt BN, Steere AC (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167:392-400
86. DuChateau BK, England DM, Callister SM, Lim LC, Lovrich SD, Schell RF (1996) Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect Immun 64:2540-2547
87. DuChateau BK, Jensen JR, England DM, Callister SM, Lovrich SD, Schell RF (1997) Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis. Infect Immun 65:2829-2836
88. DuChateau BK, Munson EL, England DM, Lovrich SD, Callister SM, Jensen JR, Schell RF (1999) Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis. J Leukoc Biol 65:162-170
89. Dunne M, al-Ramadi BK, Barthold SW, Flavell RA, Fikrig E (1995) Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect Immun 63:1611-1614
90. Duray PH (1989) Clinical pathologic correlations of Lyme disease. Rev Infect Dis 11 [Suppl 6]: S1487-S1493
91. Embers ME, Wormser GP, Schwartz I, Martin DS, Philipp MT (2007) Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease. Clin Vaccine Immunol 14:90-93
92. Engstrom SM, Shoop E, Johnson RC (1995) Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 33:419-427
93. Escudero R, Halluska ML, Backenson PB, Coleman JL, Benach JL (1997) Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy. Infect Immun 65:1908-1915
94. Exner MM, Wu X, Blanco DR, Miller JN, Lovett MA (2000) Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes. Infect Immun 68:2647-2654
95. Fikrig E, Barthold SW, Kantor FS, Flavell RA (1990) Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250:553-536
96. Fikrig E, Barthold SW, Kantor FS, Flavell RA (1991) Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis 164:1224-1227
97. Fikrig E, Barthold SW, Kantor FS, Flavell RA (1992a) Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun 60:773-777
98. Fikrig E, Telford SR 3rd, Barthold SW, Kantor FS, Spielman A, Flavell RA (1992b) Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A 89:5418-5421
99. Fikrig E, Berland R, Chen M, Williams S, Sigal LH, Flavell RA (1993) Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. Proc Natl Acad Sci U S A 90:183-187
100. Fikrig E, Bockenstedt LK, Barthold SW, Chen M, Tao H, Ali-Salaam P, Telford SR, Flavell RA (1994) Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis 169:568-574
101. Fikrig E, Barthold SW, Chen M, Grewal IS, Craft J, Flavell RA (1996) Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol 157:1-3
102. Fikrig E, Barthold SW, Chen M, Chang CH, Flavell RA (1997) Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol 159:5682-5686
103. Filgueira L, Nestle FO, Rittig M, Joller HI, Groscurth P (1996) Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 157:2998-3005
104. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton MD, Horst K, Roberts K, Hatch B, Smith HO, Venter JC (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586
105. Frey AB, Rao TD (1995) Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells. Infect Immun 63:2596-2603
106. Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G, Dellabona P, Abrignani S (2003) Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 21 [Suppl 2]:S48-S54
107. Garcia-Monco JC, Benach JL (1995) Lyme neuroborreliosis. Ann Neurol 37:691-702
108. Garcia-Monco JC, Benach JL (1997) Mechanisms of injury in Lyme neuroborreliosis. Semin Neurol 17:57-62
109. Garcia Monco JC, Wheeler CM, Benach JL, Furie RA, Lukehart SA, Stanek G, Steere AC (1993) Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci 117:206-214
110. Garcia-Monco JC, Seidman RJ, Benach JL (1995) Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun 63:4130-4137
111. Garcia-Monco JC, Miller NS, Backenson PB, Anda P, Benach JL (1997) A mouse model of Borrelia meningitis after intradermal injection. J Infect Dis 175:1243-1245
112. Gergel EI, Furie MB (2001) Activation of endothelium by Borrelia burgdorferi in vitro enhances transmigration of specific subsets of T lymphocytes. Infect Immun 69:2190-2197
113. Gergel EI, Furie MB (2004) Populations of human T lymphocytes that traverse the vascular endothelium stimulated by Borrelia burgdorferi are enriched with cells that secrete gamma interferon. Infect Immun 72:1530-1536
114. Ghosh S, Steere AC, Stollar BD, Huber BT (2005) In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J Immunol 174:2860-2869
115. Ghosh S, Seward R, Costello CE, Stollar BD, Huber BT (2006) Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J Immunol 177:2486-2494
116. Gipson CL, de Silva AM (2005) Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks. Infect Immun 73:1644-1647
117. Golightly MG (1997) Lyme borreliosis: laboratory considerations. Semin Neurol 17:11-17
118. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT (1998) Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281:703-706
119. Guerau-de-Arellano M, Huber BT (2002) Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol 14:388-393
120. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV (2000) Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1:31-36
121. Haas KM, Poe JC, Steeber DA, Tedder TF (2005) B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7-18
122. Halperin JJ (2003) Lyme disease and the peripheral nervous system. Muscle Nerve 28:133-143
123. Halperin JJ (2005) Central nervous system Lyme disease. Curr Neurol Neurosci Rep 5:446-452
124. Halperin JJ, Golightly M (1992) Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 42:1268-1270
125. Halperin JJ, Little BW, Coyle PK, Dattwyler RJ (1987) Lyme disease: cause of a treatable peripheral neuropathy. Neurology 37:1700-1706
126. Halperin JJ, Luft BJ, Anand AK, Roque CT, Alvarez O, Volkman DJ, Dattwyler RJ (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753-759
127. Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571-1582
128. Hannier S, Liversidge J, Sternberg JM, Bowman AS (2004) Characterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdorferi transmission. Immunology 113:401-408
129. Hansen K, Cruz M, Link H (1990) Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 161:1194-1202
130. Hardin JA, Steere AC, Malawista SE (1979a) Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. N Engl J Med 301:1358-1363
131. Hardin JA, Walker LC, Steere AC, Trumble TC, Tung KS, Williams RC Jr, Ruddy S, Malawista SE (1979b) Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J Clin Invest 63:468-477
132. Hardin JA, Steere AC, Malawista SE (1984) The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes. Yale J Biol Med 57:589-593
133. Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, Brade V, Miller JC, Stevenson B, Wallich R, Zipfel PF, Kraiczy P (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61:1220-1236
134. Hayes SF, Burgdorfer W, Barbour AG (1983) Bacteriophage in the Ixodes dammini spirochete, etiological agent of Lyme disease. J Bacteriol 154:1436-1439
135. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala IJ, Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276:8427-8435
136. Hodzic E, Tunev S, Feng S, Freet KJ, Barthold SW (2005) Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo. Infect Immun 73:3313-3321
137. Holliger P, Hudson PJ (2005) Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126-1136
138. Honarvar N, Schaible UE, Galanos C, Wallich R, Simon MM (1994) A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology 82:389-396
139. Horwitz MA (1984) Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell 36:27-33
140. Hovis KM, McDowell JV, Griffin L, Marconi RT (2004) Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 186:2612-2618
141. Hovis KM, Jones JP, Sadlon T, Raval G, Gordon DL, Marconi RT (2006a) Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1. Infect Immun 74:2007-2014
142. Hovis KM, Schriefer ME, Bahlani S, Marconi RT (2006b) Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever. Infect Immun 74:4519-4529
143. Hovis KM, Tran E, Sundy CM, Buckles E, McDowell JV, Marconi RT (2006c) Selective binding of Borrelia burgdorferi OspE paralogs to factor H and serum proteins from diverse animals: possible expansion of the role of OspE in Lyme disease pathogenesis. Infect Immun 74:1967-1972
144. Howe TR, Mayer LW, Barbour AG (1985) A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science 227:645-646
145. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R et al (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 85:5879-5883
146. Isakson PC, Pure E, Vitetta ES, Krammer PH (1982) T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med 155:734-748
147. Janeway C, Travers P, Walport M, Shlomchik M (2001) Immunobiology: the immune system in health and disease. Garland Publishing, New York
148. Jansson C, Carlsson SA, Granlund H, Wahlberg P, Nyman D (2005) Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA. Clin Microbiol Infect 11:147-150
149. Jensen JR, Du Chateau BK, Munson EL, Callister SM, Schell RF (1998) Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi. Infect Immun 66:1507-1512
150. Johnson BJ, Robbins KE, Bailey RE, Cao BL, Sviat SL, Craven RB, Mayer LW, Dennis DT (1996) Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 174:346-353
151. Johnson RC (1977) The spirochetes. Annu Rev Microbiol 31:89-106
152. Johnson RC, Kodner C, Russell M (1986) Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun 53:713-714
153. Kaiser R (1995) Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies. Zentralbl Bakteriol 282:303-314
154. Kaiser R, Rauer S (1998) Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur J Clin Microbiol Infect Dis 17:159-166
155. Kalish RA, Leong JM, Steere AC (1993) Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 61:2774-2779
156. Kang I, Barthold SW, Persing DH, Bockenstedt LK (1997) T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 65:3107-3111
157. Karlsson M, Mollegard I, Stiernstedt G, Wretlind B (1989) Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 8:871-877
158. Katona LI, Ayalew S, Coleman JL, Benach JL (2000) A bactericidal monoclonal antibody elicits a change in its antigen, OspB of Borrelia burgdorferi, that can be detected by limited proteolysis. J Immunol 164:1425-1431
159. Kawabata H, Masuzawa T, Yanagihara Y (1993) Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 37:843-848
160. Keane-Myers A, Nickell SP (1995a) Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155:2020-2028
161. Keane-Myers A, Nickell SP (1995b) T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol 154:1770-1776
162. Keane-Myers A, Maliszewski CR, Finkelman FD, Nickell SP (1996) Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J Immunol 156:2488-2494
163. Kochi SK, Johnson RC (1988) Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect Immun 56:314-321
164. Kochi SK, Johnson RC, Dalmasso AP (1991) Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J Immunol 146:3964-3970
165. Kochi SK, Johnson RC, Dalmasso AP (1993) Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments. Infect Immun 61:2532-2536
166. Koide S, Yang X, Huang X, Dunn JJ, Luft BJ (2005) Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA. J Mol Biol 350:290-299
167. Kraiczy P, Skerka C, Brade V, Zipfel PF (2001a) Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun 69:7800-7809
168. Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF (2001b) Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur J Immunol 31:1674-1684
169. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V (2001c) Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 1:393-401
170. Kraiczy P, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R (2003) Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur J Immunol 33:697-707
171. Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, Simon MM, Brade V, Zipfel PF, Wallich R (2004) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279:2421-2429
172. Kumararatne DS, MacLennan IC (1981) Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol 11:865-869
173. Kumararatne DS, MacLennan IC (1982) The origin of marginal-zone cells. Adv Exp Med Biol 149:83-90
174. Kumararatne DS, Bazin H, MacLennan IC (1981) Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol 11:858-864
175. Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP, Norris SJ (1999) Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37:3997-4004
176. Le Fleche A, Postic D, Girardet K, Peter O, Baranton G (1997) Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 47:921-925
177. Ledue TB, Collins MF, Craig WY (1996) New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J Clin Microbiol 34:2343-2350
178. Li L, Narayan K, Pak E, Pachner AR (2006) Intrathecal antibody production in a mouse model of Lyme neuroborreliosis. J Neuroimmunol 173:56-68
179. Liang FT, Philipp MT (1999) Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun 67:6702-6706
180. Liang FT, Alvarez AL, Gu Y, Nowling JM, Ramamoorthy R, Philipp MT (1999a) An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol 163:5566-5573
181. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT (1999b) Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 37:3990-3996
182. Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, Ruscio M, Voet PE Jr, Weynants VE, Philipp MT (2000a) Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis 182:1455-1462
183. Liang FT, Jacobson RH, Straubinger RK, Grooters A, Philipp MT (2000b) Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 38:4160-4166
184. Liang FT, Jacobs MB, Bowers LC, Philipp MT (2002) An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med 195:415-422
185. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E (2004) Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 72:5759-5767
186. Linder S, Heimerl C, Fingerle V, Aepfelbacher M, Wilske B (2001) Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex. Infect Immun 69:1739-1746
187. Lovrich SD, Callister SM, Schmitz JL, Alder JD, Schell RF (1991) Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun 59:2522-2528
188. Lovrich SD, Jobe DA, Schell RF, Callister SM (2005) Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters. Clin Diagn Lab Immunol 12:746-751
189. Luke CJ, Huebner RC, Kasmiersky V, Barbour AG (1997) Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi. Vaccine 15:739-746
190. Ma Y, Weis JJ (1993) Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 61:3843-3853
191. Ma J, Gingrich-Baker C, Franchi PM, Bulger P, Coughlin RT (1995) Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi. Infect Immun 63:2221-2227
192. Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E (2002) Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 51:649-655
193. Martin F, Kearney JF (2001) B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 13:195-201
194. Martin R, Martens U, Sticht-Groh V, Dorries R, Kruger H (1988) Persistent intrathecal secretion of oligoclonal, Borrelia burgdorferi -specific IgG in chronic meningoradiculomyelitis. J Neurol 235:229-233
195. Matyniak JE, Reiner SL (1995) T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 181:1251-1254
196. Mbow ML, Gilmore RD Jr, Titus RG (1999) An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun 67:5470-5472
197. McDowell JV, Tran E, Hamilton D, Wolfgang J, Miller K, Marconi RT (2003) Analysis of the ability of spirochete species associated with relapsing fever, avian borreliosis, and epizootic bovine abortion to bind factor H and cleave c3b. J Clin Microbiol 41:3905-3910
198. McDowell JV, Wolfgang J, Senty L, Sundy CM, Noto MJ, Marconi RT (2004) Demonstration of the involvement of outer surface protein E coiled coil structural domains and higher order structural elements in the binding of infection-induced antibody and the complement-regulatory protein, factor H. J Immunol 173:7471-7480
199. McDowell JV, Hovis KM, Zhang H, Tran E, Lankford J, Marconi RT (2006) Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect Immun 74:3030-3034
200. McKisic MD, Barthold SW (2000) T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun 68:5190-5197
201. Meier JT, Simon MI, Barbour AG (1985) Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia. Cell 41:403-409
202. Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS (2006) Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun 74:4157-4163
203. Modolell M, Schaible UE, Rittig M, Simon MM (1994) Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol Lett 40:139-146
204. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC (2004) Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. Clin Diagn Lab Immunol 11:924-929
205. Montecino-Rodriguez E, Dorshkind K (2006) New perspectives in B-1 B cell development and function. Trends Immunol 27:428-433
206. Montgomery RR, Malawista SE (1996) Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect Immun 64:2867-2872
207. Montgomery RR, Nathanson MH, Malawista SE (1993) The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery. J Immunol 150:909-915
208. Montgomery RR, Nathanson MH, Malawista SE (1994) Fc- and non-Fc-mediated phagocytosis of Borrelia burgdorferi by macrophages. J Infect Dis 170:890-893
209. Montgomery RR, Lusitani D, de Boisfleury Chevance A, Malawista SE (2002) Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J Infect Dis 185:1773-1779
210. Morshed MG, Yokota M, Nakazawa T, Konishi H (1993) Transfer of antibody against Borrelia duttonii from mother to young in ddY mice. Infect Immun 61:4147-4152
211. Munson EL, Du Chateau BK, Jobe DA, Lovrich SD, Callister SM, Schell RF (2000) Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4. Infect Immun 68:5496-5501
212. Munson EL, Du Chateau BK, Jensen JR, Callister SM, DeCoster DJ, Schell RF (2002) Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro. Clin Diagn Lab Immunol 9:1095-1101
213. Munson EL, DeCoster DJ, Nardelli DT, England DM, Callister SM, Schell RF (2004) Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice. Clin Diagn Lab Immunol 11:35-41
214. Munson EL, Nardelli DT, Luk KH, Remington MC, Callister SM, Schell RF (2006) Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro. Clin Vaccine Immunol 13:19-25
215. Murray N, Kristoferitsch W, Stanek G, Steck AJ (1986) Specificity of CSF antibodies against components of Borrelia burgdorferi in patients with meningopolyneuritis Garin-Bujadoux-Bannwarth. J Neurol 233:224-227
216. Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM (2005) A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 35:655-665
217. Neubert U, Schaller M, Januschke E, Stolz W, Schmieger H (1993) Bacteriophages induced by ciprofloxacin in a Borrelia burgdorferi skin isolate. Zentralbl Bakteriol 279:307-315
218. Newman K Jr, Johnson RC (1981) In vivo evidence that an intact lytic complement pathway is not essential for successful removal of circulating Borrelia turicatae from mouse blood. Infect Immun 31:465-469
219. Newman K Jr, Johnson RC (1984) T-cell-independent elimination of Borrelia turicatae. Infect Immun 45:572-576
220. Nieva J, Kerwin L, Wentworth AD, Lerner RA, Wentworth P Jr (2006) Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway. Immunol Lett 103:33-38
221. Novy FG, Knapp RE (1906) Studies on Spirillum obermeieri and related organisms. J Infect Dis 3:291-393
222. Nowling JM, Philipp MT (1999) Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement. Infect Immun 67:443-445
223. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156-2159
224. Oliver AM, Martin F, Kearney JF (1999) IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 162:7198-7207
225. Pachner AR, Ricalton NS (1992) Western blotting in evaluating Lyme seropositivity and the utility of a gel densitometric approach. Neurology 42:2185-2192
226. Pennington PM, Allred CD, West CS, Alvarez R, Barbour AG (1997) Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun 65:285-292
227. Philipp MT, Bowers LC, Fawcett PT, Jacobs MB, Liang FT, Marques AR, Mitchell PD, Purcell JE, Ratterree MS, Straubinger RK (2001) Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 184:870-878
228. Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, Dally LG (2005) A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme borreliosis. Clin Diagn Lab Immunol 12:1069-1074
229. Piesman J, Sinsky RJ (1988) Ability to Ixodes scapularis, Dermacentor variabilis, and Amblyomma americanum (Acari: Ixodidae) to acquire, maintain, and transmit Lyme disease spirochetes (Borrelia burgdorferi). J Med Entomol 25:336-339
230. Pillai S, Cariappa A, Moran ST (2005) Marginal zone B cells. Annu Rev Immunol 23:161-196
231. Plasterk RH, Simon MI, Barbour AG (1985) Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature 318:257-263
232. Porcella SF, Raffel SJ, Schrumpf ME, Schriefer ME, Dennis DT, Schwan TG (2000) Serodiagnosis of louse-borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis. J Clin Microbiol 38:3561-3571
233. Probert WS, Crawford M, LeFebvre RB (1997) Antibodies to OspB prevent infection of C3H mice challenged with Borrelia burgdorferi isolates expressing truncated OspB antigens. Vaccine 15:15-19
234. Rao TD, Frey AB (1995) Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone. Cell Immunol 162:225-234
235. Ras NM, Lascola B, Postic D, Cutler SJ, Rodhain F, Baranton G, Raoult D (1996) Phylogenesis of relapsing fever Borrelia spp. Int J Syst Bacteriol 46:859-865
236. Rathinavelu S, Broadwater A, de Silva AM (2003) Does host complement kill Borrelia burgdorferi within ticks? Infect Immun 71:822-829
237. Remington MC, Munson EL, Callister SM, Molitor ML, Christopherson JA, DeCoster DJ, Lovrich SD, Schell RF (2001) Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody. Infect Immun 69:4268-4275
238. Rittig MG, Krause A, Haupl T, Schaible UE, Modolell M, Kramer MD, Lutjen-Drecoll E, Simon MM, Burmester GR (1992) Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect Immun 60:4205-4212
239. Rittig MG, Jagoda JC, Wilske B, Murgia R, Cinco M, Repp R, Burmester GR, Krause A (1998) Coiling phagocytosis discriminates between different spirochetes and is enhanced by phorbol myristate acetate and granulocyte-macrophage colony-stimulating factor. Infect Immun 66:627-635
240. Rohrer JW, Gershon RK, Lynch RG, Kemp JD (1983) Enhancement of B lymphocyte secretory differentiation by a Ly 1+,2-,Qa-1+ helper T cell subset that sees both antigen and determinants on immunoglobulin. J Mol Cell Immunol 1:50-64
241. Rose CD, Fawcett PT, Gibney KM (2001) Arthritis following recombinant outer surface protein A vaccination for Lyme disease. J Rheumatol 28:2555-2557
242. Rossmann E, Kitiratschky V, Hofmann H, Kraiczy P, Simon MM, Wallich R (2006) BbCRASP-1 of the Lyme disease spirochetes is expressed in humans and induces antibody responses restricted to non-denatured structural determinants. Infect Immun 74:7024-7028
243. Rousselle JC, Callister SM, Schell RF, Lovrich SD, Jobe DA, Marks JA, Wieneke CA (1998) Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi. J Infect Dis 178:733-741
244. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B (1984) Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 149:465-470
245. Sadziene A, Jonsson M, Bergstrom S, Bright RK, Kennedy RC, Barbour AG (1994) A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun 62:2037-2045
246. Satoskar AR, Elizondo J, Monteforte GM, Stamm LM, Bluethmann H, Katavolos P, Telford SR 3rd (2000) Interleukin-4-deficient BALB/c mice develop an enhanced Th1-like response but control cardiac inflammation following Borrelia burgdorferi infection. FEMS Microbiol Lett 183:319-325
247. Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C, Simon MM (1990) Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (SCID) mice. Proc Natl Acad Sci U S A 87:3768-3772
248. Schaible UE, Wallich R, Kramer MD, Nerz G, Stehle T, Museteanu C, Simon MM (1994) Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol 6:671-681
249. Scheckelhoff MR, Telford SR, Hu LT (2006) Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine 24:1949-1957
250. Schluesener HJ, Martin R, Sticht-Groh V (1989) Autoimmunity in Lyme disease: molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid. Autoimmunity 2:323-330
251. Schmitz JL, Lovrich SD, Callister SM, Schell RF (1991) Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi. Infect Immun 59:3815-3818
252. Schmitz JL, Schell RF, Callister SM, Lovrich SD, Day SP, Coe JE (1992) Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters. Infect Immun 60:2677-2682
253. Schoenfeld R, Araneo B, Ma Y, Yang LM, Weis JJ (1992) Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun 60:455-464
254. Schroder NW, Schombel U, Heine H, Gobel UB, Zahringer U, Schumann RR (2003) Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. J Biol Chem 278:33645-33653
255. Schutzer SE, Coyle PK, Krupp LB, Deng Z, Belman AL, Dattwyler R, Luft BJ (1997) Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J Clin Invest 100:763-767
256. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA (1995) Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 92:2909-2913
257. Schwan TG, Schrumpf ME, Hinnebusch BJ, Anderson DE Jr, Konkel ME (1996) GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol 34:2483-2492
258. Schwan TG, Battisti JM, Porcella SF, Raffel SJ, Schrumpf ME, Fischer ER, Carroll JA, Stewart PE, Rosa P, Somerville GA (2003) Glycerol-3-phosphate acquisition in spirochetes: distribution and biological activity of glycerophosphodiester phosphodiesterase (GlpQ) among Borrelia species. J Bacteriol 185:1346-1356
259. Scriba M, Ebrahim JS, Schlott T, Eiffert H (1993) The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies. Infect Immun 61:4523-4526
260. Sethi N, Sondey M, Bai Y, Kim KS, Cadavid D (2006) Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun 74:6408-6418
261. Sigal LH (1993) Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J Infect Dis 167:1372-1378
262. Sigal LH (1997) Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol 15:63-92
263. Sigal LH, Tatum AH (1988) Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 38:1439-1442
264. Sigal LH, Williams S (1997) A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease. Infect Immun 65:1722-1728
265. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE (1998) A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 339:216-222
266. Simon MM, Schaible UE, Kramer MD, Eckerskorn C, Museteanu C, Muller-Hermelink HK, Wallich R (1991) Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis 164:123-132
267. Skamel C, Ploss M, Bottcher B, Stehle T, Wallich R, Simon MM, Nassal M (2006) Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J Biol Chem 281:17474-17481
268. Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947
269. Sole M, Bantar C, Indest K, Gu Y, Ramamoorthy R, Coughlin R, Philipp MT (1998) Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present. Infect Immun 66:2540-2546
270. Sood SK, Rubin LG, Blader ME, Ilowite NT (1993) Positive serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot. J Rheumatol 20:739-741
271. Southern PM, Sanford JP (1969) Relapsing fever. A clinical and microbiological review. Medicine 48:129-149
272. Spagnuolo PJ, Butler T, Bloch EH, Santoro C, Tracy JW, Johnson RC (1982) Opsonic requirements for phagocytosis of Borrelia hermsii by human polymorphonuclear leukocytes. J Infect Dis 145:358-364
273. Stanek G (1991) Laboratory diagnosis and seroepidemiology of Lyme borreliosis. Infection 19:263-267
274. Steere AC (2001) Lyme disease. N Engl J Med 345:115-125
275. Steere AC, Hardin JA, Malawista SE (1977) Erythema chronicum migrans and Lyme arthritis: cryoimmunoglobulins and clinical activity of skin and joints. Science 196:1121-1122
276. Steere AC, Hardin JA, Ruddy S, Mummaw JG, Malawista SE (1979) Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum 22:471-483
277. Steere AC, Berardi VP, Weeks KE, Logigian EL, Ackermann R (1990) Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 161:1203-1209
278. Steere AC, Gross D, Meyer AL, Huber BT (2001) Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun 16:263-268
279. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209-215
280. Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT (2003) Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 48:534-540
281. Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258
282. Stevenson B, Porcella SF, Oie KL, Fitzpatrick CA, Raffel SJ, Lubke L, Schrumpf ME, Schwan TG (2000) The relapsing fever spirochete Borrelia hermsii contains multiple, antigen-encoding circular plasmids that are homologous to the cp32 plasmids of Lyme disease spirochetes. Infect Immun 68:3900-3908
283. Stevenson B, El-Hage N, Hines MA, Miller JC, Babb K (2002) Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 70:491-497
284. Stoenner HG, Dodd T, Larsen C (1982) Antigenic variation of Borrelia hermsii. J Exp Med 156:1297-1311
285. Tai KF, Ma Y, Weis JJ (1994) Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect Immun 62:520-528
286. Takayama K, Rothenberg RJ, Barbour AG (1987) Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 55:2311-2313
287. Trollmo C, Meyer AL, Steere AC, Hafler DA, Huber BT (2001) Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J Immunol 166:5286-5291
288. U.S. Department of Health and Human Services CfDCaP (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590-591
289. Ulbrandt ND, Cassatt DR, Patel NK, Roberts WC, Bachy CM, Fazenbaker CA, Hanson MS (2001) Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies. Infect Immun 69:4799-4807
290. van Dam AP, Oei A, Jaspars R, Fijen C, Wilske B, Spanjaard L, Dankert J (1997) Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun 65:1228-1236
291. Vincent MS, Gumperz JE, Brenner MB (2003) Understanding the function of CD1-restricted T cells. Nat Immunol 4:517-23
292. von Lackum K, Miller JC, Bykowski T, Riley SP, Woodman ME, Brade V, Kraiczy P, Stevenson B, Wallich R (2005) Borrelia burgdorferi regulates expression of complement regulator-acquiring surface protein 1 during the mammal-tick infection cycle. Infect Immun 73:7398-7405
293. Wang G, van Dam AP, Le Fleche A, Postic D, Peter O, Baranton G, de Boer R, Spanjaard L, Dankert J (1997) Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol 47:926-932
294. Weinstein A, Britchkov M (2002) Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 14:383-387
295. Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA (2000) Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci U S A 97:10930-10935
296. Wentworth P Jr, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Gutierrez A, Janda KD, Babior BM, Eschenmoser A, Lerner RA (2002) Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 298:2195-2199
297. Wentworth P Jr, Wentworth AD, Zhu X, Wilson IA, Janda KD, Eschenmoser A, Lerner RA (2003) Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. Proc Natl Acad Sci U S A 100:1490-1493
298. Wheeler CM, Garcia Monco JC, Benach JL, Golightly MG, Habicht GS, Steere AC (1993) Nonprotein antigens of Borrelia burgdorferi. J Infect Dis 167:665-674
299. Whitmire WM, Garon CF (1993) Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi. Infect Immun 61:1460-1467
300. Wilkinson HW (1984) Immunodiagnostic tests for Lyme disease. Yale J Biol Med 57:567-572
301. Willett TA, Meyer AL, Brown EL, Huber BT (2004) An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc Natl Acad Sci U S A 101:1303-1308
302. Wilske B, Schierz G, Preac-Mursic V, von Busch K, Kuhbeck R, Pfister HW, Einhaupl K (1986) Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 153:304-314
303. Xu Q, Seemanapalli SV, McShan K, Liang FT (2006) Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity. Infect Immun 74:5177-5184
304. Yang JQ, Singh AK, Wilson MT, Satoh M, Stanic AK, Park JJ, Hong S, Gadola SD, Mizutani A, Kakumanu SR, Reeves WH, Cerundolo V, Joyce S, Van Kaer L, Singh RR (2003) Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J Immunol 171:2142-2153
305. Yang L, Ma Y, Schoenfeld R, Griffiths M, Eichwald E, Araneo B, Weis JJ (1992) Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun 60:3033-3041
306. Yokota M, Morshed MG, Nakazawa T, Konishi H (1997) Protective activity of Borrelia duttonii-specific immunoglobulin subclasses in mice. J Med Microbiol 46:675-680
307. Yu D, Liang J, Yu H, Wu H, Xu C, Liu J, Lai R (2006) A tick B-cell inhibitory protein from salivary glands of the hard tick, Hyalomma asiaticum asiaticum. Biochem Biophys Res Commun 343:585-590
308. Yu Z, Tu J, Chu YH (1997) Confirmation of cross-reactivity between Lyme antibody H9724 and human heat shock protein 60 by a combinatorial approach. Anal Chem 69:4515-4518
309. Zhang JR, Hardham JM, Barbour AG, Norris SJ (1997) Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285
310. Zhong W, Stehle T, Museteanu C, Siebers A, Gern L, Kramer M, Wallich R, Simon MM (1997) Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci U S A 94:12533-12538
311. Zhong W, Gern L, Stehle T, Museteanu C, Kramer M, Wallich R, Simon MM (1999) Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol 29:946-957
312. Zhu X, Wentworth P Jr, Wentworth AD, Eschenmoser A, Lerner RA, Wilson IA (2004) Probing the antibody-catalyzed water-oxidation pathway at atomic resolution. Proc Natl Acad Sci U S A 101:2247-2252